In the present study, we have identified Nogo-B as a pivotal ER-resident oncogene in the development of NAFLD-associated HCC through its role in promoting lipophagy-mediated LD turnover for oxLDL metabolism and subsequent LPA-stimulated YAP oncogenic activity (Fig. 7e). This evidence concerns the gene RTN4 and metabolic dysfunction-associated steatotic liver disease.